Tel-Aviv Sourasky MC

Tel Aviv 6423906

3 studies enrolling now · 12 studies all time

What they study most

Chronic Lymphocytic Leukemia, Colorectal Carcinoma Liver Metastases, Diabetic Macular Edema, Geographic Atrophy, Intestinal Malabsorption, Lamellar Ichthyosis, Leukemia, Lymphocytic, Chronic, B-Cell, Liver Resection, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Neovascular Age-Related Macular Degeneration

Studies at this site

Extension Study for the Port Delivery System With Ranibizumab (Portal) — Recruiting now
Safety of HRX215 in Patients After Minor and Major Liver Resection — Recruiting now
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251 — Recruiting now
A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS — Completed
A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema — Completed
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration — Completed
A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema — Completed
A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) — Completed
A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Completed
Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants — Stopped early
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA) — Completed
A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis — Stopped early